Rituximab (Rtx) is a monoclonal anti-CD20 antibody used in renal diseases with glomerular involvement, which typically presents with proteinuria. The aim of this study was to evaluate the efficacy and safety of Rituximab in the treatment of glomerular diseases and the response to this treatment.
No takes yet. Share an insight, caveat, or question.
Guerrero et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: